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The visual outcome obtained after cataract removal may progressively decline because of posterior capsular opacification (PCO).
This condition can be treated by creating an opening in the posterior lens capsule by Nd:YAG laser capsulotomy. PCO optical
imperfections cause several light reflection, refraction, and diffraction phenomena, which may interfere with the functional
and structural tests performed in different ocular locations for the diagnosis and follow-up of ocular disease, like macular and
optic nerve diseases. Some parameters measured by visual field examinations, scanning laser polarimetry, and optical coherence
tomography (OCT) have changed after PCO removal. Imaging quality also changes following capsulotomy. Consequently, the
results of ancillary tests in pseudophakic eyes for studying ocular diseases like glaucoma or maculopathies should be correlated
with other clinical examinations, for example, slit-lamp biomicroscopy or funduscopy. If PCO is clinically significant, a new baseline
should be set for future comparisons following capsulotomy when using automated perimetry and scanning laser polarimetry. To
performOCT in the presence of PCO, reliable examinations (considering signal strength) apparently guarantee that measurements
are not influenced by PCO.
1. Introduction
Phacoemulsification with implantation of intraocular lens
in the capsular bag is the most frequent surgical proce-
dure performed in ophthalmology. However, the visual gain
obtained after cataract removalmay progressively decline due
to posterior capsular opacification (PCO) [1].
Despite variations in surgical techniques, intraocular
lens material or design, implantation of additional devices,
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and pharmacological interventions, PCO remains the most
frequent long term complication after cataract surgery [1].
Published PCO rates are variable. However, a meta-analysis
concluded that approximately 25% of patients operated from
extracapsular cataract surgery suffered visually significant
PCO within 5 years of the operation [2].
PCO is due to the proliferation of lens residual epithelial
cells from the lens equator following cataract extraction,
which induces visual alteration by direct interaction with
light passing through the visual axis [3]. According to the
distribution of proliferation, the resulting opacities may
adopt a morphologic pattern or two or even a combination of
both: (a) fibrous-type PCO (fibrous epithelial layers) and (b)
pearl-type PCO (groups of swollen, optically active, opacified
grape-like epithelial growth) [4]. In clinical terms, these
changes can diminish visual acuity significantly, alter contrast
sensitivity, and cause glare and monocular diplopia [5–7].
Metaplasia of epithelial cells may also induce capsular
folds because of mechanical forces. In general terms, these
epithelial cells may transform into myofibroblasts, which
have contractile properties and allow the posterior capsule
to wrinkle [4]. These phenomena may create visual distor-
tions, including a Maddox rod effect, metamorphopsia-like
phenomena, or glare [8].
All of these effects together, these being irregular for-
mations of fibrous proliferation, pearls, and puckers of the
posterior capsule generate special properties that affect light
reflection, refraction, and diffraction, which may interfere
not only with patient vision (Figure 1), but also with func-
tional and structural ocular diagnostic tests [2].
PCO-induced visual affection can be solved by laser
Nd:YAG capsulotomy by producing an opening in the pos-
terior capsule and avoiding distortion of light in its passage
[1, 4].
An observation made before and after capsulotomy of
the outcome of different diagnostic examinations to estimate
ocular diseases provides a better understanding of the effects
of PCO on such technologies. Recent research suggests that
PCO may affect the appropriate ocular disease assessments
made by automated perimetry, scanning laser polarimetry, or
optical coherence tomography, as seen in Table 1.
2. Effect of PCO on Automated Perimetry
Avisualfield test throughwhite-on-white automated perime-
try is a widely used technique and is a useful tool for the
diagnosis and follow-up of several ocular disorders, such
as glaucoma and neuroophthalmological diseases [9, 10].
Translucent irregularities in the anterior ocular pole, for
example, cataracts or PCO, can be a confusing factor that
may lead to an inappropriate interpretation of automated
perimetry, even when it is not uncommon to encounter
patients who are affected or are suspected of being affected,
by concurrent entities, for example, PCO and glaucoma or
PCO and macular oedema.The ophthalmologist must assess
how much visual impairment is due to PCO and how much
is related to the other concomitant disorder.
The effect that cataract has on automated perimetry has
been well investigated [11–13]. Our research group completed
(a)
(b)
Figure 1: Simulation of vision in a PCO-affected eye before (a) and
after Nd:YAG capsulotomy (b).
a study in eyes of patients with PCO who underwent a
white-on-white automated perimetry test (Humphrey SITA
standard programme 24-2) immediately before Nd:YAG cap-
sulotomy and between postsurgery weeks 1 and 8 [14]. The
compared pre- and postlaser perimetric indices were mean
defect (MD) and pattern standard deviation (PSD).
MD is the average measure of how depressed the patient’s
visual field is (compared with a control of the same age).
Several researchers have reported that MD improved after
cataract surgery [11–13]. Similarly according to our results,
amelioration of MD occurred after capsulotomy [14].
PSD is a measure of how the different adjacent points
on a visual field are. If an area is focally depressed, PSD
will rise given the major difference between the points in
scotoma and their normal adjacent points. PSD remains
unchanged after cataract removal [11–13]. Compared to PCO,
however, the PSD in our study improved significantly after
capsulotomy.This change could be explained by optical PCO
features. PCO translucent opacities apparently induce erratic
light-scatter within the eye, which results in a combination
of underilluminated retinal areas and in an increased PSD.
Yet when these irregularities have been eliminated through
capsulotomy, retinal illumination can be more uniform, so
PSD lowers [14].
As the clinical slit-lamp examination aspect can be
somewhat guesswork-related and as the automated perimetry
analysis corroborates, cataracts depress an automated visual
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Table 1: Studies considering the influence of PCO on test results.
Author (year) [reference
number] Test 푛 PrecapsulotomyBCVA(mean ± SD) PostcapsulotomyBCVA(mean ± SD) Results after capsulotomy
Garc´ıa-Medina et al.
(2006) [14]. AP 26
0.35 ± 0.11
(decimal scale)
0.84 ± 0.14
(decimal scale) MD and PSD improved.
Garc´ıa-Medina et al.
(2006) [23] SLP 28
0.41 ± 0.12
(decimal scale)
0.85 ± 0.13
(decimal scale)
NFI and TSS increased. Significant
decreases of all absolute parameters.
Vetrugno et al. (2007)
[24] SLP 158
0.3 ± 0.6
(LogMar)
0.05 ± 0.2
(LogMar)
Inferior ratio and TSNIT SD
decreased. Superior/nasal increased.
Brittain et al. (2007) [25] SLP 20 0.32 ± un(LogMar) 0.14 ± un(LogMar) TSS and TSNIT SD increased. TSNITscore decreased.
Arraes et al. (2008) [26] SLP 37 0.2 ± un(decimal scale) 0.8 ± un(decimal scale) No significant difference betweenparameters.
Hougaard et al. (2001)
[35] TD-OCT 13
0.29 ± un
(decimal scale)
0.39 ± un
(decimal scale)
Signal-to-noise ratio increased but no
changes in macular thickness.
Garcia-Medina et al.
(2007) [32] TD-OCT 32
0.25 ± 0.17
(decimal scale)
0.77 ± 0.22
(decimal scale)
SS increased but no changes in pRNFL
thicknesses (in reliable exams).
Gonza´lez-Ocampo-
Dorta et al. (2008)
[40]
TD-OCT 32 0.25 ± 0.17(decimal scale) 0.77 ± 0.22(decimal scale) SS increased but no changes inmacular thicknesses (in reliableexams).
Altiparmak et al. (2010)
[36] TD-OCT 54
0.47 ± 0.3
(decimal scale)
0.91 ± 0.14
(decimal scale) No change of the foveal thickness.
Giocanti-Aure´gan et al.
(2011) [37] TD-OCT 30
0.6 ± 0.3
(LogMar)
0.1 ± 0.3
(LogMar) No change of the foveal thickness.
Wro´blewska-Czajka et al.
(2012) [38] TD-OCT 55 NA NA
No change of the central macular
thickness.
Kara et al. (2012) [31] TD-OCT 98 0.49 ± 0.28(LogMar) 0.09 ± 0.11(LogMar) SS and pRNFL thicknesses increased.
Garcia-Medina et al.
(2013) [34] SD-OCT 37
0.27 ± 0.19
(decimal scale)
0.83 ± 0.18
(decimal scale)
All pRNFL thickness parameters
increased. No changes when
considering reliable examinations.
Garcia-Medina et al.
(2013) [41] SD-OCT 35
0.23 ± 0.28
(decimal scale)
0.81 ± 0.16
(decimal scale)
All macular thickness parameters
increased. No changes when
considering reliable examinations.
Ruiz-Casas et al. (2013)
[39] SD-OCT 31 0.4 ± NA 0.8 ± NA No change of the foveal thickness.
BCVA: best-corrected visual acuity, SD: standard deviation, AP: automated perimetry, MD: mean deviation, PSD: pattern standard deviation, SLP: scanning
laser polarimetry, NFI: nerve fiber indicator, TSS: typical scan score, TSNIT: temporal-superior-nasal-inferior-temporal, NA: not available, TD-OCT: time
domain optical coherence tomography, SD-OCT: spectral domain optical coherence tomography, SS: signal strength, and pRNFL = peripapillary retinal nerve
fiber layer.
field quite uniformly. So they constitute homogeneous opaci-
ties. However, PCOs depress the visual field heterogeneously.
Therefore, they have been demonstrated as being polymor-
phous opacities that may even mimic pathological patterns
[14], such as glaucoma arcuate scotoma, which are susceptible
to elimination after capsulotomy (Figure 2).
In conclusion, PCO has proven to be a heterogeneous
mean opacity. This polymorphism may alter visual field
results. For practical purposes, a perimetric defect produced
by a PCO can be confused in some cases with a pathologic
perimetric defect (false-positive). Consequently, presence of
PCO should be taken into account while evaluating any
automated perimetry in eyes operated from cataracts.
3. Influence of Posterior
Capsular Opacification on Scanning
Laser Polarimetry
Scanning laser polarimetry (SLP) is a technology for esti-
mating retinal nerve fibre layer (RNFL) thickness in vivo
at a specific location [15]. It is based on the principle that
a polarised laser beam changes its polarisation status when
passing through a birefringent tissue. The RNFL is made
up of highly ordered parallel axon bundles that contain
microtubules, which is the source of its birefringence [15].
As polarised light passes through the RNFL and is reflected
back, it undergoes a phase shift. This change in polarisation
4 BioMed Research International
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Figure 2: Perimetric defect thatmimics inferior arcuate scotoma in a PCO-affected eye (a).The defect partially disappeared after capsulotomy
(b).
(retardation), as measured by SLP, correlates with RNFL
thickness [16, 17].Therefore, SLP allows a quantitative assess-
ment of the degree of thinning of the peripapillary RNFL.
Such information has been demonstrated as being clinically
useful in screening and following up both glaucoma [18–20]
and nonglaucomatous optic neuropathies, such as anterior
ischaemic optic neuropathy, optic nerve head drusen, and
demyelinating optic neuritis [21].
Nevertheless, the RNFL is not the only birefringent struc-
ture in the eye. The anterior segment also has birefringent
properties, mainly the cornea. Therefore, total retardation
of a subject’s eye is the sum of both the anterior segment
and RNFL birefringence. Accuracy of SLP measurements
depends on the ability to isolate RNFL retardation from total
ocular retardation [21].
To reduce the effect of anterior segment polarisation, the
newest GDx generation incorporates a variable corneal com-
pensator (VCC) that enables compensation of the anterior
segment birefringence (ASB) in each individual eye [21].
Several researchworks into the effect that PCOand subse-
quent Nd:YAG capsulotomy have on the SLP results of RNFL
retardation measurements have been conducted [22–26].
With this purpose in mind, our research group performed
a study into PCO-affected eyes and SLP, selected using GDx
VCC, on each patient before and after capsulotomy. We
compensated ASB before doing any SLP examination. We
compared the SLP parameters before and after PCO removal.
We concluded that PCO removal is associated with remark-
ably significant changes in all the SLP measurements. Briefly,
our results suggest that thickness parameters are higher
before than after capsulotomy. In other words, SLP exami-
nation with GDx VCC may overestimate RNFL retardation
measurements in PCO-affected eyes.Therefore, the glaucoma
diagnosis in PCO can be underestimated on the basis of the
SLP results (false-negatives) (Figure 3) [22, 23]. Furthermore,
some SLP measurements (nasal average and nerve fibre indi-
cator) have been significantly associated with best-corrected
Nerve fiber layer
(a)
Nerve fiber layer (microns)
0 20 40 60 80 100 120
(b)
Figure 3: Scanning laser polarimetry examination before (a) and
after Nd:YAG capsulotomy (b). Note that the thickness measure-
ments reduce after PCO removal.
visual acuity (BCVA) before capsulotomy,which suggests that
this technology may be useful for quantifying the degree
of PCO [23]. However other authors have not found as
many changes in the GDx parameters before and after
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PCO removal. Vetrugno et al. [24] reported modifications
in symmetry, inferior ratio, superior, nasal, and temporal-
superior-nasal-inferior-temporal SD whereas Brittain et al.
[25] showed significant changes in the typical scan score
and temporal-superior-nasal-inferior-temporal average. In
addition, Arraes et al. did not show any significant difference
between the thickness parameters before and after posterior
capsulotomy in patients with moderate degrees of PCO [26].
The variability of the results can be related to the fact that
anterior segment birefringence is only assessed before and
after laser capsulotomy [23] or only before capsulotomy [25].
The characteristics of the population included in these studies
can also be related to this variability noted in the results [23–
25].
We also performed a study on a new series of PCO
affected eyes that supports our previous conclusions of GDx
VCC measurements. In this study we also observed that
corneal polarisation axis and corneal polarisation magnitude
(the two parameters that determine ASB) changed signifi-
cantly after PCO removal [27, 28].
Although the results of different studies in the literature
are not fully coincident, it is advisable to not only repeat the
SLP examination after capsulotomy to serve as a new baseline
for the future but also recompensate ASB after Nd:YAG laser
application to obtain reliablemeasurements using GDxVCC.
4. Effect of PCO on Optical
Coherence Tomography
Optical coherence tomography (OCT) generates high reso-
lution, 2-dimensional cross-sectional images of the internal
microstructure of ocular structures. Transverse images of the
device are produced using low coherence tomography, an
optical measuring technique that is analogous to a B-scan
ultrasound, but instead of sound waves, OCT uses a laser-
generated beam of light. Two kinds of OCT are available to
date: time domain OCT and, more recently, spectral domain
OCT. Although both types of OCT use the same basic
working principles, the scan rate and axial resolution have
improved in spectral domain OCT [29].
OCT explored structures like the peripapillary RNFL
and the central retina (including total macular thickness).
RNFL thickness, measured by OCT, has been used to study
glaucomatous neuropathy, anterior ischaemic optic neuropa-
thy, optic nerve head drusen, demyelinating optic neuritis,
traumatic optic tract lesion, Leber hereditary optic neuropa-
thy, and toxic optic neuropathy [21]. Macular assessment by
OCT has proved to be a very useful tool for studying the
vitreoretinal interface, intraretinal oedema, neuroepithelial
detachment, impairments in normal retina architectonics,
and its pigment epithelium or choroidal disorders, no matter
what its aetiology is [30].
In theory, PCOoptical translucent imperfections can alter
this beam of light and can, consequently, induce artifactual
results in OCT thickness and quality parameters. Several
studies have been performed to answer this question.
In relation to peripapillary RNFL measurements, Kara
et al. [31] recently investigated the effect that PCO has on
the results of RNFL thickness measured by time domain
OCT (Stratus, Zeiss).These authors divided eyes into groups
according to each signal strength (SS) value obtained, includ-
ing unreliable (SS < 5) and reliable examinations (SS > 5).
They also compared the thickness in each group indepen-
dently and observed that the lower the SS value, the greater
the precapsulotomy RNFL average underestimation and the
more significant the results. They concluded that RNFL
thickness is affected by PCO. Our group previously carried
out a similar study with time domain OCT (Stratus, Zeiss)
[32, 33]. We also obtained a significant increase in SS but
found no changes in RNFL thicknesses after capsulotomy in
reliable scans.When considering all the scans (reliable: SS≥ 6
and unreliable examinations: SS < 6), we concluded that PCO
induces an underestimation of RNFL thickness parameters
(Figure 4) as measured by spectral domain OCT (Cirrus,
Zeiss). However when analyzing only reliable examinations,
no changes between pre- and postlaser measurements were
observed [34]. This finding suggests that the prelaser SS
value may orientate the degree of reliability of the results, as
previously described by Kara et al. [31].
As far as the central retina is concerned, macular thick-
ness parameters have also been compared before and after
Nd:YAG capsulotomy in several studies in order to directly
assess OCT performance or to indirectly check the safety of
the procedures for evaluating macular cystoid oedema as a
complication of PCO removal. Most research has shown in
both the short and long term that macular thickness param-
eters, as measured by OCT, have not been seen to change
after Nd:YAG laser capsulotomy [35–39]. In one study by our
group performed with time domain OCT (Stratus, Zeiss),
we concluded that OCT image quality is influenced by PCO.
Nd:YAG capsulotomy results in a measurable improvement
in quality and improves the number of valuable examinations.
However, valuable OCT scans in patients with PCO did not
show changes in macular thickness measurements, not even
in the presence of severe PCO [40]. In a more recent study
using spectral domain OCT (Cirrus, Zeiss), we concluded
that all the parameters in the comparisons thickness were
higher after capsulotomy than theywere before (Figure 5). Yet
when we considered only patients with a signal strength of≥6 (reliable scans), no significant differences were observed
in the measurements taken before and after PCO removal
[41].
5. Additional Comments
Some other concerns should be taken into account when
considering the influence of PCO on the above-mentioned
tests. Firstly, PCOmay have different patterns, that is, central,
paracentral, and diffuse ones, which may differently affect
the quality and the results of functional and structural tests.
The example of the visual field may reflect a paracentral PCO
(Figure 2). However to the best of our knowledge, this fact
has not been considered in studies to date. Secondly, some
data indicate the relation between degree of PCO and test
abnormality. Degree of PCO could have also been estimated
directly by BCVA. In one study on automated perimetry, the
correlation results revealed that BCVA, MD, and PSD were
6 BioMed Research International
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Figure 4: OCT maps of RNFL thickness before (a) and after (b) capsulotomy. Note that thickness measurements increase in the top half of
the map after PCO removal.
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Figure 5: OCT maps of total macular thickness before (a) and after (b) the capsulotomy. Note that most of the thickness measurements
increase and image quality improves after PCO removal.
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significantly associated both before and after capsulotomy
[14]. Another study showed some SLP measurements asso-
ciated significantly with BCVA before capsulotomy, which
indicates that this technology may be useful for quantifying
degree of PCO [23]. In relation to OCT, the correlation found
between BCVA and SS before capsulotomy suggests that SS
could be considered an objective indicator of degree of PCO
[40]. Kara et al. [31] also found a significant correlation
between, on the one hand, preoperative BCVA and SS and,
on the other hand, between preoperative BCVA and degree
of PCO. Finally, differences between instruments may be due
to, at least in part, differences in inclusion criteria between
studies and characteristics of included eyes.
6. Conclusion
Optical translucent imperfections of PCO induce special
properties relating to reflection, refraction, and diffraction
that may alter the ancillary tests used in the diagnosis and
follow-up of different optic nerve diseases.
In fact the results of automated perimetry and SLP have
been shown to change after capsulotomy. In addition, OCT
quality imaging of RNFL thickness is influenced by PCO.
However, no change has been observed after PCO removal in
the retinal nerve fibre layer parameters of pseudophakic eyes
by reliable examinations before capsulotomy, as measured by
OCT.
Thus, features of ancillary tests in pseudophakic eyes for
studying optic nerve diseases should be well-interpreted and
should correlate with other clinical examinations, such as
slit-lamp biomicroscopy. If a clinically significant PCO is
detected, newmeasurements should be considered after PCO
removal to serve as a baseline for future comparisons, espe-
cially when using automated perimetry and SLP. As for OCT
in the presence of PCO, reliable examinations (considering
signal strength) apparently guarantee that the measurements
taken before and after capsulotomy are similar.
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